World
Archived — This article has been archived. The information may be outdated.
India envoy pitches Chinese investment and pharma exports
The Hindu··5 Jul
Ambassador Vikram Doraiswami told Beijing's World Peace Forum on July 4 that greater Chinese investment would benefit India-China economic ties. He urged easier Indian pharmaceutical exports to China and noted trade reached $151.1 billion in 2025-26 with a $112.16 billion deficit. India relaxed China-linked investment restrictions in March after 2020 Press Note 3 curbs.
Prism
What It Means For You
- Indian generic drug makers seeking China market access could benefit if Beijing eases entry for pharmaceuticals already exported to the US.
- Manufacturers importing Chinese machinery and intermediate goods may see smoother investment rules after March relaxations on four China-linked firms.
- A lopsided $112 billion trade deficit means most consumer imports from China continue to outpace Indian exports.
What's Happening
- Ambassador Doraiswami spoke on July 4 at the World Peace Forum panel on protectionism and global economic governance in Beijing.
- He said India wants to export more, especially pharmaceuticals where it holds global competitiveness.
- Commerce Ministry data shows China was India's largest trading partner in 2025-26 with $151.1 billion bilateral trade.
Trade After the LAC Freeze
- Relations froze after 2020 border clashes; normalisation began after PM Modi met President Xi Jinping in October 2024.
- India continues importing electrical machinery and finished goods from China while seeking value-added manufacturing partnerships.
- Doraiswami said India is willing to handhold Chinese businesses entering the market under changed investment rules.
all-newstop-storiesdaily-roundup
